Dendritic Cell vaccination using
Showing 1 - 25 of >10,000
Melanoma, Uveal Metastatic Trial in Erlangen (Vaccination with IKKb matured Dendritic Cells)
Active, not recruiting
- Melanoma, Uveal Metastatic
- Vaccination with IKKb matured Dendritic Cells
-
Erlangen, Bavaria, GermanyUniversity Hospital Erlangen Dept. of Dermatology
Mar 16, 2022
Melanoma Trial in Philadelphia (Mature dendritic cell (DC) vaccine, Cyclophosphamide 300mg/m^2, Pembrolizumab)
Active, not recruiting
- Melanoma
- Mature dendritic cell (DC) vaccine
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Feb 2, 2023
Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)
Not yet recruiting
- Esophageal Cancer
- +3 more
- IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
-
Edegem, BelgiumAntwerp University Hospital
Jul 19, 2023
Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))
Active, not recruiting
- Renal Cancer
- Dendritic Cell Tumor Fusion Vaccine
- Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 2, 2023
NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)
Active, not recruiting
- Non-small Cell Lung Cancer
- Dendritic cell immunotherapy
- +2 more
-
Ghent, BelgiumGhent University Hospital
Dec 23, 2022
Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell
Not yet recruiting
- Cytomegaloviral Infection
- Hematopoietic and Lymphoid System Neoplasm
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 16, 2022
Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)
Not yet recruiting
- Epithelial Ovarian Cancer
- Ovarian Carcinoma
- XP-DC vaccinations
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Mar 6, 2023
Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP
Completed
- Prostate Specific Antigens
- Prostate Neoplasms
- T-cell receptor alternate reading frame protein (TARP) peptide vaccine
- T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 15, 2022
Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)
Completed
- Stage III Malignant Melanoma of Skin AJCC V6
- Stage IV Malignant Melanoma of Skin
- TAPCells vaccine
-
Santiago, RM, ChileFaculty of Medicine, University of Chile
Nov 21, 2023
Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Diffuse Hemispheric Glioma, H3 G34-Mutant
- Dendritic Cell Tumor Peptide Vaccine
- +6 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 13, 2022
Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2023
Prostatic Tumors, Prostate Cancer Trial run by the NCI (Autologus elutriated monocyte vaccine, Multi-epitope (ME) T-cell
Terminated
- Prostatic Neoplasms
- Prostate Cancer
- Autologus elutriated monocyte placebo vaccine
- Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2022
Multiple Myeloma Trial in Boston (Nivolumab, DC/myeloma fusions/GM-CSF)
Terminated
- Multiple Myeloma
- Nivolumab
- DC/myeloma fusions/GM-CSF
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Sep 28, 2022
Recurrent Ovarian Cancer Trial in Chengdu (dendritic cell)
Not yet recruiting
- Recurrent Ovarian Cancer
- dendritic cell
-
Chengdu, Sichuan, Chinawest china second University, SICHUAN University, China
Feb 25, 2022
Glioblastoma Trial in Camden, Houston (TH-1 Dendritic Cell Immunotherapy)
Recruiting
- Glioblastoma
- TH-1 Dendritic Cell Immunotherapy
-
Camden, New Jersey
- +1 more
Jun 27, 2022
Multiple Myeloma Trial in United States (procedure, drug, biological)
Completed
- Multiple Myeloma
- Tumor Cell Collection
- +6 more
-
San Francisco, California
- +14 more
Jul 11, 2022
Multiple Myeloma Trial in New York (CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care)
Completed
- Multiple Myeloma
- CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs)
- Standard of care
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 22, 2022
Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,
Not yet recruiting
- Malignant Pleural Mesothelioma
- Dendritic cell vaccination
- +2 more
-
Edegem, Antwerp, Belgium
- +2 more
Feb 28, 2023
Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (GM-CSF, Dendritic Cell/Tumor Fusion Vaccine,
Active, not recruiting
- Ovarian Cancer
- +2 more
- GM-CSF
- +2 more
-
Boston, Massachusetts
- +3 more
Jan 25, 2022
Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard
Completed
- Glioblastoma
- +4 more
- Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
- Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 18, 2021
GBM Trial in Taichung, Taoyuan (autologous dendritic cells)
Recruiting
- GBM
- autologous dendritic cells
-
Taichung, Non-US, Taiwan
- +2 more
Mar 21, 2022
Pancreatic Ductal Adenocarcinoma Trial in Philadelphia (mDC3/8-KRAS Vaccine)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- mDC3/8-KRAS Vaccine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Apr 4, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Edegem (Dendritic cell vaccination + temozolomide-based
Recruiting
- High Grade Glioma
- Diffuse Intrinsic Pontine Glioma
- Dendritic cell vaccination + temozolomide-based chemoradiation
- Dendritic cell vaccination +- conventional next-line treatment
-
Edegem, BelgiumUnitversity Hospital Antwerp
Sep 13, 2021
Breast Cancer Trial in Dallas (LA TNBC: DC vaccine+Preop chemo, ER+/HER2-BC:DC vaccine+Preop chemo)
Completed
- Breast Cancer
- LA TNBC: DC vaccine+Preop chemo
- ER+/HER2-BC:DC vaccine+Preop chemo
-
Dallas, TexasBaylor University Medical Center
Oct 7, 2021
Acute Myeloid Leukemia Trial in Oslo (WT1/PRAME vaccination)
Completed
- Acute Myeloid Leukemia
- WT1/PRAME vaccination
-
Oslo, NorwayOslo University Hospital, Rikshospitalet
Jul 6, 2020